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The mitogen-activated protein kinase (MAPK) signaling pathway, which is conserved
from yeast to humans, is activated in response to a variety of extra- and intracellular
stimuli, and plays key roles in multiple cellular processes, including proliferation,
differentiation, and apoptosis. The MAPK pathway transmits its signal through the
sequential phosphorylation of MAPK kinase kinase to MAPK kinase to MAPK. Spe-
cific and efficient activation of the MAPK cascades is crucial for proper cellular
responses to stimuli. As shown in yeast, the mammalian MAPK signaling system may
also employ scaffold proteins, in part, to organize the MAPK signaling components
into functional MAPK modules, thereby enabling the efficient activation of specific
MAPK pathways. This review article describes recent advances in the study of poten-
tial mammalian scaffold proteins that may help us understand the complex regula-
tion, including the spatial and temporal control, of the mammalian MAPK signaling
pathways.
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The mitogen-activated protein kinase (MAPK) signal
transduction pathway is evolutionarily well conserved
among eukaryotes (1). This pathway includes three
kinases, MAPK kinase kinase (MAP3K), MAPK kinase
(MAPKK), and MAPK. These proteins form a signaling
module in which a phosphorylation relay occurs from
MAP3K to MAPKK to MAPK. Extensive studies of three
groups of mammalian MAPK cascades, the ERK, p38,
and JNK cascades, have uncovered two qualitatively dif-
ferent aspects of the signaling pathways. First, the
MAPK cascades play pivotal roles in multiple cellular
processes, including proliferation, differentiation, and
apoptosis (2, 3). Second, there exist a number of mamma-
lian MAPK signaling components that form complex sig-
naling networks in cells. To date, fifteen MAP3Ks, seven
MAPKKs, and ten MAPKs have been reported (3, 4). Fur-
thermore, in many cases, alternative splicing produces
several isoforms of the relevant signaling components.
The mammalian MAPK cascades can be activated by a
variety of stimuli, and each of the cascades preferentially
responds to a distinct set of stimuli (3). Conversely, mul-
tiple distinct MAPK modules can also be activated by a
common stimulus. For example, the inflammatory
cytokines tumor necrosis factor α and interleukin-1 can
number of signaling components involved in mammalian
MAPK cascades and the complex modes of activation of
the MAPK modules, it follows that cells have developed
mechanisms by which the signaling components behave
not as independent molecules, but as signaling modules,
thereby enabling the specific and efficient activation of
distinct MAPK signaling modules in parallel.
In yeast, this sequestration of MAPK signaling compo-
nents into functional modules is mediated by scaffold
proteins (1). The yeast scaffold protein Ste5p possesses
no enzymatically functional domain, but is essential for
the yeast mating pheromone pathway. Ste5p selectively
binds a signaling module consisting of MAP3K Ste11p,
MAPKK Ste7p, and MAPK Fus3p, and connects this
module to upstream activators. Likewise, mammalian
cells appear to employ, at least in part, a similar strategy
to ensure signaling specificity and efficiency (Fig. 1; 3, 5,
6). Table 1 summarizes the proposed scaffold proteins in
mammals. The study of these proteins may shed light on
the complex regulation, including the spatial and tempo-
ral control, of the MAPK signaling pathways, and how
the proper cellular responses to stimuli are elicited.
Putative Scaffold Proteins for MAPK Signaling Mod-
ules—JIP1 and its homologue. JIP1 is the founding mem-
ber of a novel family of mammalian MAPK scaffold pro-
teins. It was identified by a yeast two-hybrid system
using JNK MAPK as bait (7). Transfection assays have
demonstrated that JIP1 selectively binds the signaling
components of all three levels of a JNK signaling module,Vol. 135, No. 6, 2004 657 © 2004 The Japanese Biochemical Society.
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that coexpression of JIP1 with the three kinases facili-
tates the activation of JNK (7). It is assumed that JIP1
organizes the MLK/MKK7/JNK module stoichiometri-
cally and enhances the phosphorylation relay, leading to
the activation of JNK. Overexpression of JIP1 alone dis-
rupts the normal signal transduction pathway, probably
by sequestering signaling molecules, thus acting as an
inhibitor of JNK signaling (8). A theoretical study of
MAPK scaffolds by Levchenko et al. (9) supports this sce-
nario. They termed this effect, “combinatorial inhibition.”
It is likely that having the correct stoichiometric amount
of scaffold proteins relative to the relevant kinases is cru-
cial for proper signal transduction. In pancreatic β-cells,
JIP1 appears to suppress JNK activity, which is released
during cytokine-induced apoptosis with a concomitant
reduction in JIP1 (10). Although the molecular mecha-
nism of this suppression remains unclear, it might be due
in part to the “combinatorial inhibition” effect. JIP1 has
recently been shown to bind the MAPK phosphatase
MKP7, implying that JIP1 modulates JNK signaling
through association with both protein kinases and phos-
phatases (11). Studies using JIP1-deficient adult mice
and primary neurons have demonstrated that JIP1 is
required for excitotoxic stress-induced neuronal apopto-
sis, which is likely to be mediated by JIP1-regulated JNK
cascades (12). It has also been reported that a JIP1 defi-
ciency in mice leads to early embryonic death (13). The
reason for these different phenotypes is unknown.
JIP2, another member of the JIP group of scaffold pro-
teins, is structurally similar to JIP1, and was initially
shown to assemble JNK signaling modules in a manner
similar to JIP1 (14, 15). Recent studies, however, suggest
JIP2 acts as a scaffold in p38 MAPK signaling pathways
(16, 17).
JSAP1 and its homologue. JSAP1 was identified as a
JNK-binding protein (18, 19) that is structurally unre-
lated to JIP1/2. JSAP1 is expressed abundantly in the
brain and nervous system (18–20). Transfection experi-
ments suggest that JSAP1 may coordinate several dis-
tinct JNK signaling modules, containing ASK1, MEKK1,
and MLK3 as the MAP3K, and enhance the MAP3K-
induced activation of JNK (18, 19, 21). JSAP1 has also
been identified as a TLR4-interacting protein and shown
to be involved in LPS-mediated JNK activation, where it
connects MEKK1-JNK cascades with TLR4 (22). In addi-
tion, JSAP1 might also function as a suppressor for ERK
signaling (23). A targeted gene-disruption study demon-
strated that JSAP1 is required for telencephalon mor-
phogenesis (24). The JSAP1-deficient mice die shortly
after birth, most likely due to a failure to breathe (24).
Although the mechanism that accounts for the breathing
failure is unclear, neuronal defects associated with the
JSAP1 deficiency may be implicated in this phenotype.
An in vitro differentiation study with JSAP1-deficient
mouse ES cells demonstrated that JSAP1 is important
during early embryonic neurogenesis (25).
Another protein, JLP, shares considerable sequence
homology with JSAP1 and was shown to bind MAP3K
MEKK3, MAPKK MKK4, and the MAPKs JNK and p38α
when these molecules were coexpressed in cells (26).
Thus, JLP might function as a scaffolding protein in both
the JNK and p38 cascades.
KSR—KSR was originally identified in Ras-dependent
genetic screens in Drosophila and Caenorhabditis ele-
gans as a positive effector of Ras-MAPK signaling (27).
Accumulating evidence indicates that KSR functions as a
scaffold to coordinate the Ras-mediated Raf/MEK/ERK
signaling pathway in the fly, worm, and vertebrates (27).
Recent RNA interference experiments in Drosophila and
C. elegans (28, 29), and studies with KSR-deficient mice
(30) confirmed that KSR is required for Ras-mediated
ERK pathway activation.
MP1, POSH, and β-Arrestin—Transfection assays dem-
onstrated that MP1, a MEK-binding protein, specifically
binds MAPKK MEK1 (but not MEK2) and MAPK ERK1
(but not ERK2), and enhances the activation of ERK1,
suggesting a scaffold role of MP1 in ERK signaling (31).
To date, no MAP3K has been reported to interact with
MP1. POSH was identified as a protein that interacts
with Rac, a member of the small GTPase Rho family (32),
and transfection experiments suggested POSH to be a
scaffold protein in the MLK-JNK apoptotic cascade (33).
β-arrestins are well known as terminators in G-protein-
coupled receptor (GPCR) signaling (34). Recent data sug-
Fig. 1. Schematic illustration of the role of scaffold proteins
in MAPK signaling. The scaffold protein organizes MAPK signal-
ing molecules as a functional module, thereby enabling efficient
activation of the specific MAPK module in response to a stimulus.
Table 1. Mammalian scaffold proteins for MAPK signaling
pathways.
aND, not determined; bNI, no interaction.
Name Alternate name







Filamin ABP-280 NDa-MKK4-NDa (38)
JIP1 IB1 MLK-MKK7-JNK (7)
JIP2 IB2 MLK-MKK7-JNK (14, 15)
MLK-MKK3-p38α (16)
MLK-NDa-p38δ (17)
JLP MEKK3-MKK4-JNK, p38α (26)







SKRP1 ASK1-MKK7-JNK (39)J. Biochem.
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teins in the ERK and JNK3 cascades (35–37).
Other Potential Scaffolds—Recent studies suggest
there may be other mammalian MAPK signaling scaffold
proteins in addition to those described above, e.g., Fil-
amin, an actin-binding protein (38), SKRP1, a MAPK
phosphatase (39), and OSM (osmosensing scaffold for
MEKK3), a MEKK3-binding protein (40).
Dynamic Regulation of MAPK Signaling Modules
Mediated by Scaffold Proteins—MAPK scaffold proteins
may function merely to increase the local concentration
of their associated signaling components, as suggested by
a study using artificial scaffold proteins (41). However,
more dynamic models of the regulation of the mamma-
lian MAPK signaling modules through scaffold proteins
have also been presented. Nihalani et al. (42) proposed
the following model based on their experimental data:
JIP1 maintains the MLK family member DLK in a mono-
meric and catalytically inactive state. Upon stimulation,
the JIP1-JNK binding affinity increases and the DLK-
JIP1 affinity decreases, allowing DLK dimerization, acti-
vation, and subsequent module activation. Kim et al. (43)
found an interaction between Akt1, a member of the Akt
family that regulates a diverse array of biological proc-
esses including cell survival, and JIP1, and proposed the
following model: Akt1 negatively regulates JIP1’s scaf-
folding activity. In response to an excitotoxic stimulus,
the Akt1-JIP1 interaction decreases and concomitantly
the JIP1-JNK association increases, leading to JNK-
mediated neuronal apoptosis. A similar regulation
scheme has been reported for the Akt2-POSH interac-
tion. Figueroa et al. (44) identified Akt2 as a POSH-bind-
ing protein and revealed that the binding of Akt2 to
POSH down-regulates POSH’s scaffold activity. FGF
homologous factors and two Rac-GEFs, Tiam1 and Ras-
GFR1, have been shown to interact with JIP2, and
appear to positively regulate JIP2’s scaffold activity (16,
17). In addition, Matsuura et al. (21) proposed a dynamic
regulation of the ASK1-JNK signaling pathway by the
scaffold protein JSAP1 in which the stimulation-depend-
ent phosphorylation of JSAP1 by ASK1 positively regu-
lates JSAP1’s scaffold activity.
Kinesin-Mediated Transport and Scaffold Proteins—
The specific subcellular localization of signaling modules
in response to stimuli is likely to be required for specific
biological responses. There is evidence supporting the
idea that the JIP1/2 and JSAP1 scaffold proteins are
involved in the trafficking of MAPK modules. Verhey et
al. (45) reported that these scaffold proteins interact with
conventional kinesin, which consists of KHC and KLC, in
a yeast two-hybrid system using KLC as bait. They also
suggested that JIP1 acts as cargo for the kinesin, on
which JIP1 appears to preload its associated proteins,
such as MAP3K DLK and the Reelin receptor ApoER
(45). In addition, amyloid precursor protein (APP) has
been shown to interact with JIP1 and JIP2, and JIP1
may modulate APP metabolism to affect processing and
secretion (46). JIP1 might also mediate the kinesin-
dependent axonal transport of APP (47, 48). Further-
more, genetic studies in C. elegans and Drosophila estab-
lished a functional relationship between JSAP1 and con-
ventional kinesin (49, 50). The physiological relationship
between JSAP1 and JNK signaling has also been clari-
fied by genetic studies in C. elegans (50); worms contain-
ing mutations in JSAP1 exhibit similar characteristics to
those with mutations in JNK signaling components.
Mutations in C. elegans JSAP1, JNK, and JNK kinase
result in the mislocalization of synaptic vesicle markers.
Recently, Setou et al. (51) suggested that JSAP1 is a
determinant of the traffic direction of the motor protein.
They showed that JSAP1 steers conventional kinesin to
the axon in cultured neurons. Together, these studies
indicate that some scaffold proteins such as JIP1 and
JSAP1 may actually translocate MAPK modules along
microtubules with kinesin to a specific destination. To
date, however, it is not known whether the MAPK
modules themselves are also involved in the spatial
regulation.
Stimulus-Dependent Targeting of MAPK Modules by
Scaffold Proteins—Morrison’s group has proposed a
model based on their extensive studies, which nicely
accounts for mammalian KSR function: In quiescent
cells, KSR is located in the cytoplasm and constitutively
interacts with MAPKK MEK and 14-3-3 protein, which
regulates protein function through binding to phospho-
serine-containing motifs (27). In response to growth fac-
tor treatment, KSR translocates to the plasma mem-
brane with MEK and recruits ERK; the KSR complex
then provides a platform on which Raf activated by Ras
can begin the phosphorylation relay from Raf to MEK to
ERK. During this process, the KSR-associated proteins
14-3-3, Cdc25C-associated kinase C-TAK (52), and pro-
tein phosphatase 2A (53) function as key molecules in
regulating the intracellular localization of the KSR scaf-
fold complex and its activity.
Recent data suggest that β-arrestins facilitate GPCR-
stimulated ERK and JNK3 activation and target acti-
vated MAPK modules to specific locations within cells,
for example, to the leading edges of motile cells (34, 54).
p14, a protein copurifying with late endosomes/
lysosomes, has been identified as an MP1-binding pro-
tein, and subsequently, Teis et al. (55) demonstrated that
p14 is required for the targeting of the MP1 scaffold
complex to endosomes and for efficient ERK signaling
upon EGF-stimulation.
Future Perspectives—One of the most exciting areas in
recent studies of mammalian MAPK cascades has been
the identification of putative scaffold proteins. Research
on the properties and roles of scaffold proteins contrib-
utes greatly to our understanding of complex intracellu-
lar signaling networks in mammalian cells. Although
there has been intense research activity in this field, the
following issues still need to be considered and clarified.
One key issue undoubtedly continues to be the identifi-
cation of the components of each endogenous scaffold
complex, in which we need to take into account the fact
that mammalian MAPK modules may be dynamically
regulated by scaffold proteins in response to stimuli, and
furthermore, that each scaffold protein might independ-
ently organize more than one distinct MAPK module in
vivo.
It is still nebulous how the scaffold proteins enable the
efficient activation of the relevant signaling components
in response to stimuli. Detailed biochemical analyses of
these processes are required. It also needs to be clarified
how the activated MAPK dissociates from the relevantVol. 135, No. 6, 2004
660 K. Yoshiokascaffold protein to modulate its effectors. Moreover, crys-
tallographic studies of the scaffold proteins should pro-
vide useful information about their structure and inter-
actions.
The possible role of scaffold proteins in the termination
of MAPK signaling also needs to be explored. Because
disrupting the MAPK scaffolding complexes would result
in the rapid disassembly of functional MAPK modules, it
is possible that scaffold proteins regulate the termination
of MAPK signaling by modulating their own stability.
It is largely unknown what the physiologically rele-
vant extracellular stimuli are that activate the MAPK
scaffold complexes. Furthermore, the physiological roles
of the various scaffold proteins remain to be elucidated.
Thus, classical and conditional gene-disruption studies
will be crucial in providing this information. In addition,
a knock-in strategy might be useful whereby a mutant
scaffold protein impairing the interaction with MAPK,
for example, is expressed at the physiological level. This
genetic approach could clarify whether the scaffold pro-
teins possess MAPK-independent biological functions.
The author thanks Drs. M. Ito (Kitasato University) and T. Ito
(BIRD, JST and Kanazawa University) for helpful comments
on the manuscript.
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